Phase 2 Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials
8 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–8 of 8 trials
Recruiting
Phase 2
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Progressive Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)
Avalyn Pharma Inc.340 enrolled52 locationsNCT06951217
Recruiting
Phase 2
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis (IPF)
Rein Therapeutics120 enrolled9 locationsNCT06968845
Recruiting
Phase 2
AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
Idiopathic Pulmonary Fibrosis (IPF)
Avalyn Pharma Inc.160 enrolled3 locationsNCT07194382
Recruiting
Phase 2
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Idiopathic Pulmonary Fibrosis (IPF)
Vicore Pharma AB360 enrolled117 locationsNCT06588686
Recruiting
Phase 2
SB17170 Phase 2 Trial in IPF Patients
Idiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)IPF
SPARK Biopharma30 enrolled5 locationsNCT06747923
Recruiting
Phase 2
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis (IPF)
InSilico Medicine Hong Kong Limited40 enrolled12 locationsNCT05975983
Active
Phase 2
Access to Pirfenidone Solution for Inhalation (AP01) for Treatment of Progressive, Fibrosing Interstitial Lung Diseases, including Idiopathic Pulmonary Fibrosis
Progressive, fibrosing interstitial lung diseaseIdiopathic Pulmonary Fibrosis (IPF)
Avalyn Pharma Pty Ltd100 enrolled13 locationsACTRN12621000170820
Recruiting
Phase 2
A Phase 2 study to evaluate the safety and tolerability of ACT001 in treating adults with Progressing Fibrosing Interstitial Lung Disease (PF-ILD), including Idiopathic Pulmonary Fibrosis (IPF)
Progressing Fibrosing Interstitial Lung Disease (PF-ILD)Idiopathic Pulmonary Fibrosis (IPF)
Accendatech Au Pty Ltd40 enrolled1 locationACTRN12619001643167